Manhattan Scientifics Inc (MHTX)

[ssc]

That's interesting news, gives a fairly clear picture of where things stand. After 7 years and burning thru $20 million or more, they are just now arriving at this point:

Working with StarFish, the Company will establish the clinical instrument design specifications and StarFish will provide Imagion with a mockup of the instrument before committing to the building of prototypes for human studies and market development.

So as Proulx has stated before, the design for human testing has yet to be established. People can judge for themselves how many more years, how much more cash, how much additional dilution lie ahead. Yes, things are moving forward, but so are competing technologies.

Do you believe mhtx shareholders will ever profit from their 29% (and very likely to be further diluted) share of the Flynn technology? Or are ibx shares a better choice even though future fund raising will have a more direct dilutive affect?